Scyx stock nasdaq

SCYNEXIS, Inc. (SCYX): Price and Financial Metrics Stocks that are quantitatively similar to SCYX, based on their financial statements, market capitalization, and price volatility, are FIXX, GERN, Scynexis Inc (SCYX) Stock Price | Nasdaq (NASDAQ:SCYX) has 50 institutional investors and shareholders that have filed 13D/G or 13F forms with the Securities Exchange Commission (SEC). These  View SCYX stock info; drug pipeline; latest news; SEC filings; articles; upcoming 13, 2020 /PRNewswire/ -- SCYNEXIS, Inc. (NASDAQ:SCYX), a biotechnology 

Nov 07, 2019 · All quotes are in local exchange time. Real-time last sale data for U.S. stock quotes reflect trades reported through Nasdaq only. Intraday data delayed at least 15 minutes or per exchange SCYX | SCYNEXIS Inc. Stock Price & News - WSJ View the latest SCYNEXIS Inc. (SCYX) stock price, news, historical charts, analyst ratings and financial information from WSJ. SCYNEXIS - SCYX - Stock Price & News | The Motley Fool Apr 02, 2020 · Founded in 1993 by brothers Tom and David Gardner, The Motley Fool helps millions of people attain financial freedom through our website, podcasts, books, …

SCYNEXIS Inc. historical stock charts and prices, analyst ratings, financials, and today’s real-time SCYX stock price.

SCYX Stock Quote of Scynexis Inc - InvestorPlace Aug 29, 2018 · Check out our SCYX stock analysis, current SCYX quote, charts, and historical prices for Scynexis Inc stock. DOW / Nasdaq / (NASDAQ:SCYX) in 2015. This report will, first, examine the CEO SCYNEXIS, INC. : SCYX Stock Price | MarketScreener SCYNEXIS, Inc. is engaged in the discovery, development and commercialization of anti-infectives. The Company is developing its lead product candidate, SCY-078, as an oral and intravenous (IV) drug for the treatment of several fungal infections, including serious invasive fungal infections. SCYNEXIS (SCYX) Stock Message Board - InvestorsHub Lead product is SCY-078 for the treatment of several serious fungal infections. Both oral and new IV formulations are now in Phase I with results expected in June and July 2016. Is It Right Time to Be Cautious on SCYNEXIS Inc. (NASDAQ ...

SCYNEXIS, Inc. (SCYX): Price and Financial Metrics Stocks that are quantitatively similar to SCYX, based on their financial statements, market capitalization, and price volatility, are FIXX, GERN, Scynexis Inc (SCYX) Stock Price | Nasdaq

SCYX | Complete SCYNEXIS Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview. 23 Mar 2020 Real-time trade and investing ideas on SCYNEXIS SCYX from the NASDAQ 3.79% $SCYX my grandpa told me to buy this stock, so I did. 2.

NASDAQ:SCYX Big picture: it is currently in uptrend channel. Higher highs and lower lows, tightening pattern. Smaller picture, its underneath EMAs, so that's a bit concerning. But volume looks to be increasing more steadily.

SCYX - Short squeeze stock short interest data and short selling information for shares of Scynexis Incorporated. Short interest stock data available for NASDAQ,   (NASDAQ: SCYX) today announced the pricing of its previously announced underwritten public offering of 38,888,889 shares of common stock and warrants to  SCYNEXIS Inc (SCYX) 0.81 +0.04 +5.19% NASDAQ Apr 3, 20:00 Delayed 2m USD. Switch To Sector Update: Health Care Stocks Rise 1% on Wednesday Stock and Warrants. Dec 12 2019, 12:46 PM EST. Symbol. SCYX. Exchange. Nasdaq. Market Cap. 104.07m. Last Price. $1.07. 52-Week. $0.67 - $1.90. 12 Dec 2019 (NASDAQ : SCYX) today announced the closing of its previously announced underwritten public offering of 38,888,889 shares of common stock  13 Mar 2020 The shares of SCYNEXIS Inc. (NASDAQ:SCYX) has been pegged with a 2018, to Buy the SCYX stock while also putting a $6 price target.

Van Meerten Stock Picks. Jim Van Meerten's Daily Stock Picks highlights stocks you might want to consider for your portfolio, with Jim's editorials about current events and stock market commentary. Jim Van Meerten uses Barchart's tools to offer daily stock picks and recommendations. His portfolios have been honored by Marketocracy and Morningstar.

SCYNEXIS Inc. SCYXU.S.: Nasdaq. Quote. 19 Mar 2020 Needham equity researchers changed the status of SCYNEXIS, Inc. (NASDAQ: SCYX) shares from “Hold” to a “Buy” rating in the report published  20 Mar 2020 The recent performance of SCYNEXIS (NASDAQ:SCYX) stock in the market spoke loud and clear to… SCYX - Short squeeze stock short interest data and short selling information for shares of Scynexis Incorporated. Short interest stock data available for NASDAQ,   (NASDAQ: SCYX) today announced the pricing of its previously announced underwritten public offering of 38,888,889 shares of common stock and warrants to  SCYNEXIS Inc (SCYX) 0.81 +0.04 +5.19% NASDAQ Apr 3, 20:00 Delayed 2m USD. Switch To Sector Update: Health Care Stocks Rise 1% on Wednesday

Jan 13, 2020 · Today, we will be studying why Scynexis is an attractive investment for 2020.Company overview. Scynexis is a clinical-stage biopharmaceutical company focused on … SCYX Stock Price, Forecast & News (SCYNEXIS) | MarketBeat Analyzing SCYNEXIS (NASDAQ:SCYX) stock? View SCYX's stock price, price target, earnings, financials, forecast, insider trades, news, and SEC filings at MarketBeat. SCYX Price Target and Analyst Ratings (SCYNEXIS) | MarketBeat Oct 30, 2019 · Their average twelve-month price target is $4.63, suggesting that the stock has a possible upside of 500.65%. The high price target for SCYX is $6.00 and the low price target for SCYX is $3.50. There are currently 6 buy ratings for the stock, resulting in a consensus rating of "Buy."